A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Replimune Inc.
Linnaeus Therapeutics, Inc.
TScan Therapeutics, Inc.
Novelty Nobility, Inc.
Turnstone Biologics, Corp.
Provectus Pharmaceuticals
Opna Bio LLC
Pfizer
Incyte Corporation